Irene Fasciani

Irene Fasciani

Auto-generated profile, based on publicly available information

Irene Fasciani

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Brain Research
Verified
Journal Article
Closed access
SRStefania Romeo
Stefania Romeo
FVFlora Vitale
Flora Vitale
CVCristina Viaggi
Cristina Viaggi
SMStefano Di Marco
Stefano Di Marco
GAGabriella Aloisi
Gabriella Aloisi
RMRoberto Maggio
Roberto Maggio

7 January 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
BLBiancamaria Longoni
Biancamaria Longoni
IFIrene Fasciani
Irene Fasciani
SKShivakumar Kolachalam
Shivakumar Kolachalam
IPIlaria Pietrantoni
Ilaria Pietrantoni
FMFrancesco Marampon
Francesco Marampon
RMRoberto Maggio
Roberto Maggio
: Exosomes are extracellular vesicles produced by eukaryotic cells that are also found in most biological fluids and tissues. While they were initially thought to act as compartments for removal of cellular debris, they are now recognized as important tools for cell-to-cell communication and for the transfer of pathogens between the cells. They have attracted particular interest in neurodegenerative diseases for their potential role in transferring prion-like proteins between neurons, and in Parkinson’s disease (PD), they have been shown to spread oligomers of α-synuclein in the brain accelerating the progression of this pathology. A potential neuroprotective role of exosomes has also been equally proposed in PD as they could limit the toxicity of α-synuclein by clearing them out of the cells. Exosomes have also attracted considerable attention for use as drug vehicles. Being nonimmunogenic in nature, they provide an unprecedented opportunity to enhance the delivery of incorporated drugs to target cells. In this review, we discuss current knowledge about the potential neurotoxic and neuroprotective role of exosomes and their potential application as drug delivery systems in PD.

1 March 2015 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
MCMarta Capannolo
Marta Capannolo
IFIrene Fasciani
Irene Fasciani
SRStefania Romeo
Stefania Romeo
GAGabriella Aloisi
Gabriella Aloisi
MRMario Rossi
Mario Rossi
RMRoberto Maggio
Roberto Maggio

27 February 2020 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
ACAlessandro Colapietro
Alessandro Colapietro
GGGiovanni Luca Gravina
Giovanni Luca Gravina
FPFrancesco Petragnano
Francesco Petragnano
IFIrene Fasciani
Irene Fasciani
Bianca Maria ScicchitanoBianca Maria Scicchitano
Bianca Maria Scicchitano
FMFrancesco Marampon
Francesco Marampon
Erythropoietin-producing hepatocellular receptors (Eph) promote the onset and sustain the progression of cancers such as colorectal cancer (CRC), in which the A2 subtype of Eph receptor expression has been shown to correlate with a poor prognosis and has been identified as a promising therapeutic target. Herein, we investigated, in vitro and in vivo, the effects of treatment with GLPG1790, a potent pan-Eph inhibitor. The small molecule has selective activity against the EphA2 isoform in human HCT116 and HCT15 CRC cell lines expressing a constitutively active form of RAS concurrently with a wild-type or mutant form of p53, respectively. GLPG1790 reduced EPHA2 phosphorylation/activation and induced G1/S cell-cycle growth arrest by downregulating the expression of cyclin E and PCNA, while upregulating p21Waf1/Cip1 and p27Cip/Kip. The inhibition of ephrin signaling induced quiescence in HCT15 and senescence in HCT116 cells. While investigating the role of CRC-related, pro-oncogenic p53 and RAS pathways, we found that GLPG1790 upregulated p53 expression and that silencing p53 or inhibiting RAS (human rat sarcoma)/ERKs (extracellular signal-regulated kinase) signaling restrained the ability of GLPG1790 to induce senescence in HCT116 cells. On the other hand, HCT15 silencing of p53 predisposed cells to GLPG1790-induced senescence, whilst no effects of ERK inhibition were observed. Finally, GLPG1790 hindered the epithelial-mesenchymal transition, reduced the migratory capacities of CRC, and affected tumor formation in xenograft models in vivo more efficiently using HCT116 than HCT15 for xenografts. Taken together, our data suggest the therapeutic potential of GLPG1790 as a signal transduction-based therapeutic strategy in to treat CRC.

18 January 2024 in Neuroscience
Verified
Journal Article
Open access
IFIrene Fasciani
Irene Fasciani
FPFrancesco Petragnano
Francesco Petragnano
FBFederica Bono
Federica Bono
GAGabriella Aloisi
Gabriella Aloisi
VMVeronica Mutti
Veronica Mutti
MRMario Rossi
Mario Rossi
Our recent study revealed that fluorescent lamp light can penetrate deep into the brain of mice and rats leading to the development of typical histological characteristics associated with Parkinson's disease such as the loss of dopamine neurons in the substantia nigra. Monochromatic LED lights were thus used in this work to deepen our knowledge on the effects of the major wavelength peaks of fluorescent light on mouse and human dopaminergic cells. In particular, we exposed immortalized dopaminergic MN9D neuronal cells, primary cultures of mouse mesencephalic dopaminergic cells and human dopaminergic neurons differentiated from induced pluripotent stem cells (hiPSC) to different LED light wavelengths. We found that chronic exposure to LED light reduced overall undifferentiated MN9D cell number, with the most significant effects observed at wavelengths of 485 nm and 610 nm. Moreover, LED light especially at 610 nm was able to negatively impact on the survival of mouse mesencephalic dopaminergic cells and of human dopaminergic neurons derived from hiPSC. Notably, differentiated MN9D dopaminergic cells, which closely resemble mature dopamine neuronal phenotype, acutely exposed for 3 h at 610 nm, showed a clear increase in ROS production and cytotoxicity compared to controls undifferentiated MN9D cells. These increases were even more pronounced by the co-treatment with the oxidative agent H2O2. Collectively, these findings suggest that specific wavelengths, particularly those capable of penetrating deep into the brain, could potentially pose an environmental hazard in relation to Parkinson's disease.

1 January 2014 in Epilepsy Research
Verified
Journal Article
Closed access
MCMarta Capannolo
Marta Capannolo
CCCarmela Ciccarelli
Carmela Ciccarelli
RMRaffaella Molteni
Raffaella Molteni
FFFabio Fumagalli
Fabio Fumagalli
CRCristina Rocchi
Cristina Rocchi
RMRoberto Maggio
Roberto Maggio